Medical Company Joins Forces With Artificial Intelligence Subsidiary

In an era where obesity has become a global epidemic, the quest for effective treatments has never been more urgent. Recent advancements in artificial intelligence (AI) have opened new doors in the fight against obesity, with Hoth Therapeutics' wholly-owned subsidiary Merveille.ai leading the charge. Their groundbreaking approach to discovering potential obesity therapeutics is not just a glimmer of hope; it's a beacon of innovation that could transform millions of lives around the world. $ $Hoth Therapeutics(HOTH.US)$